🔴 Humacyte is trading 6% down as recent decline continues

Humacyte is trading at $0.42 (-6.13%), with no identified company-specific catalyst for the October 9 decline.

• Shares also fell 5.34% on October 8, continuing the recent downward trend.
• The latest located company release was a September 9 Symvess shelf-life update.
• The biotech sector reportedly rose 2.50%, and major U.S. indexes were modestly higher; these moves do not explain Humacyte’s decline.